Skip to content
Capsule Allopathic

Miltefos 50 mg capsule

Generic: Miltefosine

Company: Not listed yet. Prices are as listed on BestinMeds; your pharmacy price may differ.

Strength50 mg
PackNot listed yet

Reviewed by: not listed yet. Source: not listed yet.

Last updated September 7, 2024.

Compare

Same generic, same strength

Sorted by price per capsule. Ask your pharmacist before you switch brands.

Miltefosine 50 mg capsules

Prices as listed on BestinMeds.

1 brand listed
Miltefos (this medicine)165.00 taka per capsule

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250
Medicine guide

About this medicine

What this medicine is for, how to take it, and what to watch for.

Read the full Miltefosine guide

Indications

Visceral leishmaniasis Miltefosine is an antileishmanial drug indicated in adults and adolescents ≥12 years of age weighing ≥30 kg (66 lbs) for treatment of: Visceral leishmaniasis due to Leishmania donovani. Cutaneous leishmaniasis due to Leishmania braziliensis, Leishmania guyanensis, and Leishmania panamensis. Mucosal leishmaniasis due to Leishmania braziliensis.

Dosage and administration

Administer with food to ameliorate gastrointestinal adverse reactions. 30 to 44 kg: one 50 mg capsule twice daily for 28 consecutive days. 45 kg or greater: one 50 mg capsule three times daily for 28 consecutive days.

Side effects

Adverse reactions occurring in ≥2% of patients include nausea, vomiting, diarrhea, headache, decreased appetite, dizziness, abdominal pain, pruritus, somnolence, elevated transaminases, and elevated creatinine.

Precautions and warnings

Embryo-Fetal Toxicity. Do not use in pregnant women. Obtain a urine or serum pregnancy test prior to initiation of therapy. Advise use of effective contraception in females of reproductive potential. Reproductive effects. Miltefosine caused testicular atrophy and impaired fertility in male rats and impaired fertility in female rats. Advise patients of reproductive toxicities in animal studies and that the potential effects on human fertility have not been adequately evaluated. Renal Effects. Monitor serum creatinine during therapy and for 4 weeks after end of therapy. Hepatic Effects. Monitor transaminases and bilirubin during therapy. Gastrointestinal Effects. Encourage fluid intake. Thrombocytopenia. Monitor platelet count during therapy for visceral leishmaniasis. Absorption of Oral Contraceptives. Advise use of alternative method of contraception if vomiting and/or diarrhea occur. Stevens-Johnson syndrome. Discontinue miltefosine.

Pregnancy and lactation

Pregnancy: Miltefosine should not be used during pregnancy. Obtain a urine or serum pregnancy test in females of reproductive potential prior to prescribing.Nursing Mothers: Discontinue drug or nursing depending on the importance of drug to the mother. Avoid breastfeeding for 5 months after Miltefosine therapy.Females and Males of Reproductive Potential: Advise females to use effective contraception during therapy and for 5 months after therapy. Advise patients of reproductive toxicities in animals, and that the potential for impaired fertility in humans has not been adequately evaluated

Clinical details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250